• Início
  • Resultados da busca
  • Differentiation of lung stem/progenitor cells into alveolar pneumocytes and induction of angiogenesis within a 3D gelatin--microbubble scaffold.

Differentiation of lung stem/progenitor cells into alveolar pneumocytes and induction of angiogenesis within a 3D gelatin--microbubble scaffold.

Biomaterials (2014-04-22)
Thai-Yen Ling, Yen-Liang Liu, Yung-Kang Huang, Sing-Yi Gu, Hung-Kuan Chen, Choa-Chi Ho, Po-Nien Tsao, Yi-Chung Tung, Huei-Wen Chen, Chiung-Hsiang Cheng, Keng-Hui Lin, Feng-Huei Lin
RESUMO

The inability to adequately vascularize tissues in vitro or in vivo is a major challenge in lung tissue engineering. A method that integrates stem cell research with 3D-scaffold engineering may provide a solution. We have successfully isolated mouse pulmonary stem/progenitor cells (mPSCs) by a two-step procedure and fabricated mPSC-compatible gelatin/microbubble-scaffolds using a 2-channel fluid jacket microfluidic device. We then integrated the cells and the scaffold to construct alveoli-like structures. The mPSCs expressed pro-angiogenic factors (e.g., b-FGF and VEGF) and induced angiogenesis in vitro in an endothelial cell tube formation assay. In addition, the mPSCs were able to proliferate along the inside of the scaffolds and differentiate into type-II and type-I pneumocytes The mPSC-seeded microbubble-scaffolds showed the potential for blood vessel formation in both a chick chorioallantoic membrane (CAM) assay and in experiments for subcutaneous implantation in severe combined immunodeficient (SCID) mice. Our results demonstrate that lung stem/progenitor cells together with gelatin microbubble-scaffolds promote angiogenesis as well as the differentiation of alveolar pneumocytes, resulting in an alveoli-like structure. These findings may help advance lung tissue engineering.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Hemoglobin from bovine blood, lyophilized powder
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, ≥98% (TLC)
Sigma-Aldrich
Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Rabbit IgG (whole molecule), F(ab′)2 fragment–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 5A6, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 2H4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 4H2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 4C10, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 4D9, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 2B3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 1D3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 4E2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 4A8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 2B2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 1B9, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RCV1 antibody produced in mouse, clone 1B7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-RCVRN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution

Redes sociais

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Pesquisa. Desenvolvimento. Produção.

Somos um fornecedor global líder para o setor de ciências biológicas, com soluções e serviços para pesquisa, desenvolvimento e produção de biotecnologia, além de produção e desenvolvimento de terapias farmacológicas com medicamentos.

© 2021 Merck KGaA, Darmstadt, Alemanha e/ou suas filiais. Todos os direitos reservados.

A reprodução não autorizada de quaisquer materiais deste site é estritamente proibida.